Clinical trial
Leveraging Evidence-based Practices for Ambulatory VTE and Other Patients to be Safe With Direct Oral Anticoagulants: LEAVE Safe With DOACs
NCT04068727 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Leveraging Evidence-based Practices for Ambulatory VTE and Other Patients to be Safe With Direct Oral Anticoagulants: LEAVE Safe With DOACs
- Lead sponsor
- University of Massachusetts, Worcester
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 2, 2019
- Completion date
- September 14, 2022
- Enrollment
- 561 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.